# Metformin and Simvastatin in Addition to Fulvestrant

> **NCT03192293** · PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 28 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Metformin/Simvastatin/Fulvestrant

## Key facts

- **NCT ID:** NCT03192293
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-20
- **Primary completion:** 2019-01-20
- **Final completion:** 2019-01-20
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03192293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03192293, "Metformin and Simvastatin in Addition to Fulvestrant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03192293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*